EPAS1 and hepatocellular carcinoma: The results indicate that the HIF-2α expression was up-regulated in HepG2 cells and Huh7 cells in a hypoxic environment, and overexpression of HIF-2α significantly increased the viability of hepatocellular carcinoma cells and reduced their sorafenib sensitivity.